Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis (Q38138322)

29 August 2017

0 references

Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis (English)

1 reference

29 August 2017

1 reference

1 reference

Bhadran Bose

1

1 reference

29 August 2017

Sunil V Badve

2

1 reference

29 August 2017

Swapnil S Hiremath

3

1 reference

29 August 2017

Alan Cass

6

1 reference

29 August 2017

Carmel M Hawley

11

1 reference

29 August 2017

13

Suetonia C Palmer

1 reference

29 August 2017

Vlado Perkovic

14

1 reference

29 August 2017

Giles Walters

18

1 reference

29 August 2017

19

David W Johnson

1 reference

29 August 2017

4

Neil Boudville

1 reference

29 August 2017

15

Elaine M Pascoe

1 reference

29 August 2017

7

Janak R de Zoysa

1 reference

29 August 2017

16

Gopala K Rangan

1 reference

29 August 2017

Fiona G Brown

5

1 reference

29 August 2017

Robert G Fassett

8

1 reference

29 August 2017

Randall Faull

9

1 reference

29 August 2017

David C Harris

10

1 reference

29 August 2017

John Kanellis

12

1 reference

29 August 2017

Robert J Walker

17

1 reference

29 August 2017

language of work or name

English

0 references

publication date

15 September 2013

1 reference

Nephrology Dialysis Transplantation

29 August 2017

1 reference

29 August 2017

29

1 reference

29 August 2017

406-413

1 reference

29 August 2017

2

1 reference

Prevalence of chronic kidney disease in the United States

29 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lif

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Association of dialysis modality and cardiovascular mortality in incident dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

A role for uric acid in the progression of renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Challenges of conducting a trial of uric-acid-lowering therapy in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Uric acid as a target of therapy in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Clinical outcome of hyperuricemia in IgA nephropathy: a retrospective cohort study and randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Allopurinol treatment and its effect on renal function in gout: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

Renal function in gout: long-term treatment effects of febuxostat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT378

21 January 2018

Identifiers

DOI

10.1093/NDT/GFT378

1 reference

29 August 2017

1 reference